Inositide-Dependent Nuclear Signalling in Health and Disease.
Cancer
Disease
Nuclear inositides
Journal
Handbook of experimental pharmacology
ISSN: 0171-2004
Titre abrégé: Handb Exp Pharmacol
Pays: Germany
ID NLM: 7902231
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
1
1
2020
medline:
13
8
2020
entrez:
1
1
2020
Statut:
ppublish
Résumé
Nuclear inositides have a specific subcellular distribution that is linked to specific functions; thus their regulation is fundamental both in health and disease. Emerging evidence shows that alterations in multiple inositide signalling pathways are involved in pathophysiology, not only in cancer but also in other diseases. Here, we give an overview of the main features of inositides in the cell, and we discuss their potential as new molecular therapeutic targets.
Identifiants
pubmed: 31889219
doi: 10.1007/164_2019_321
doi:
Substances chimiques
Phosphatidylinositols
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM